From the gain‐ and loss‐of‐function of MeCP2 and HOXD3, MeCP2 promoted the expression of HOXD3 via the HB‐EGF cell signaling pathway to induce migration, invasion, and angiogenesis in HCC. The gene discussed is HOXD3; the disease is hepatocellular carcinoma.